Remove 2001 Remove Data Remove History Remove Treatment
article thumbnail

Psych Newsletter UK Interviews MP, Crispin Blunt

Cannabis Law Report

The constitutional convention saw the campaign to reschedule psilocybin elevated to national headlines, and a week later British psychedelic company COMPASS Pathways released data from its pivotal Phase IIb trial with psilocybin, which demonstrated its efficacy in treatment-resistant depression.

Policy 52
article thumbnail

India: Bar & Bench Article: Is it time to decriminalise Cannabis use in India?

Cannabis Law Report

The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. Further, while enacting the NDPS Act, Parliament did not take into consideration the positive effects of cannabis on human health and the history of use of cannabis in India, the petition stated.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US Conference of Mayors: 89th Annual Meeting Federal Cannabis Regulation Discussion & Resolutions

Cannabis Law Report

Patent 6630507, which identifies the medicinal benefits of cannabinoids, the compounds found in cannabis; and WHEREAS, in 2013, the American Civil Liberties Union (ACLU) published an unprecedented national report on cannabis possession arrests, “The War on Marijuana in Black and White” which analyzed data from all 50 states and the District (..)

Policy 98
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.

article thumbnail

Austria: Cannabidiol In Food And Cosmetics

Cannabis Law Report

A medicinal product by function has a significant influence on the human physiological functions by a pharmacological effect in connection with the prevention or treatment of a disease or has a medical-therapeutical benefit 5 . and derived products containing cannabinoids as novel foods as a history of consumption has not been demonstrated.

Food 40
article thumbnail

Article – Reed Smith: UK: Cannabis In The UK – A Regulatory Environment In Transition?

Cannabis Law Report

The main relevant UK legislation is the Misuse of Drugs Act 1971 (the Act) and the Misuse of Drugs Regulations 2001 (as amended by the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018) (the Regulations). No data is available regarding prescriptions written in respect of secondary care.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. It also has an extensive and diverse history of medicinal use. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Data collection. 2018 ; Frankhauser 2008 ).